24 min
George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs PeerVoice Clinical Pharmacology Audio
-
- Science
Visit https://www.peervoice.com/TUZ860 to view the entire programme with slides. After completing “George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs”, participants will be able to: Describe the role of nonsteroidal mineralocorticoid receptor antagonists (MRAs) as part of an overall treatment strategy to improve renal and cardiovascular outcomes for patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM); Outline the emerging standards of care for management of patients with CKD and T2DM, based on the “four-pillar” approach; Explain the rationale for the recent updates in management guidelines for patients with CKD and T2DM; and Apply clinical evidence and recommendations to practice in the management of patients with CKD and T2DM, highlighting the role of nonsteroidal MRAs.
Visit https://www.peervoice.com/TUZ860 to view the entire programme with slides. After completing “George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAs”, participants will be able to: Describe the role of nonsteroidal mineralocorticoid receptor antagonists (MRAs) as part of an overall treatment strategy to improve renal and cardiovascular outcomes for patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM); Outline the emerging standards of care for management of patients with CKD and T2DM, based on the “four-pillar” approach; Explain the rationale for the recent updates in management guidelines for patients with CKD and T2DM; and Apply clinical evidence and recommendations to practice in the management of patients with CKD and T2DM, highlighting the role of nonsteroidal MRAs.
24 min